Please provide us with your name and email to access exclusive resource content

Thank you you for requesting this content.
Click here for access
Oops! Something went wrong while submitting the form.
Quick adme quote
Connect your science
Connect with us
Poster

Poster

Introducing BioPALS – A Versatile Hit Identification Technology Powered by AI and Enabled by GCI

Close-up of a colorful fanned-out magazine or book pages showing curved layers.

We have developed BioPALS, an innovative, lean and versatile hitidentification platform combining AI-powdered virtual screeningwith cutting-edge biophysical technologies. BioPALS enables therapid identification and comprehensive characterisation of hits.The implementation of this technology is exemplified here usingthe BRPF1b bromodomain for which BioPALS identified a range ofpotent, selective and lead-like hits, thus offering newopportunities for the treatment of AML and many other cancers.

DOWNLOAD RESOURCELISTEN HEREREAD MOREWATCH HERE

Alternatively, search our entire resource library here

Explore related content

Assay Card
ADMET, DMPK and Toxicology
Poster
Accelerating PROTAC Development: A Direct-to-Biology Approach for Rapid Synthesis and Profiling of PROTACS
Assay Card
Advancing Drug Discovery with 3D Spheroid Cancer Models
Brochure
BioPALS Brochure
Case Study
Case Study - GMP Manufacture of CLS7001
Poster
Combining AI-driven virtual screening with biophysics to identify novel BRPF1b inhibitors
Poster
Design, Preparation, and Screening of BRPF1b Degraders
Poster
Development of a selective WEE1 inhibitor
Poster
Electrochemical de-aromatisation and derivatisation of fragments
Case Study
Accelerating your API to Clinic
Case Study
Applying understanding of protein structure to support drug discovery progress for Apini Therapeutics
Case Study
Integrated Approach to Cyclic Peptide Discovery
Case Study
Peptide Lead Optimization